Garcia-Hernandez V, Torres-Roman A, Ruiz-Garcia E, Santamaria A, Manzo-Merino J, Garcia-Lopez A
Int J Mol Sci. 2025; 26(5).
PMID: 40076652
PMC: 11900069.
DOI: 10.3390/ijms26052033.
Melo E, Asevedo E, Duarte-Almeida J, Nurkolis F, Syahputra R, Park M
Plants (Basel). 2025; 14(4).
PMID: 40006844
PMC: 11859785.
DOI: 10.3390/plants14040585.
Wan X, Ma J, Bai H, Hu X, Ma Y, Zhao M
Biomolecules. 2025; 15(1).
PMID: 39858534
PMC: 11764138.
DOI: 10.3390/biom15010140.
Lu J, Jiang C, Drabick J, Joshi M, Perimbeti S
Pharm Res. 2025; 42(1):25-47.
PMID: 39779619
PMC: 11785709.
DOI: 10.1007/s11095-024-03809-9.
Garajova I, Giovannetti E
Cancers (Basel). 2025; 16(24.
PMID: 39766161
PMC: 11674953.
DOI: 10.3390/cancers16244260.
NGF-mediated crosstalk: unraveling the influence of metabolic deregulation on the interplay between neural and pancreatic cancer cells and its impact on patient outcomes.
Trentini F, Agnetti V, Manini M, Giovannetti E, Garajova I
Front Pharmacol. 2024; 15:1499414.
PMID: 39723256
PMC: 11668609.
DOI: 10.3389/fphar.2024.1499414.
Unraveling TRPV1's Role in Cancer: Expression, Modulation, and Therapeutic Opportunities with Capsaicin.
Chinreddy S, Mashozhera N, Rashrash B, Flores-Iga G, Nimmakayala P, Hankins G
Molecules. 2024; 29(19).
PMID: 39407657
PMC: 11477668.
DOI: 10.3390/molecules29194729.
SUMOylation-induced membrane localization of TRPV1 suppresses proliferation and migration in gastric cancer cells.
Yang Y, Gu X, Weng W, Cheng J, Huang O, Pan S
Cell Commun Signal. 2024; 22(1):465.
PMID: 39350261
PMC: 11441086.
DOI: 10.1186/s12964-024-01850-0.
Capsaicin: a spicy way in liver disease.
Li S, Hao L, Yu F, Li N, Deng J, Zhang J
Front Pharmacol. 2024; 15:1451084.
PMID: 39281271
PMC: 11392895.
DOI: 10.3389/fphar.2024.1451084.
Unveiling Drimenol: A Phytochemical with Multifaceted Bioactivities.
Yang Z, Chan K, Bakar M, Deng X
Plants (Basel). 2024; 13(17).
PMID: 39273976
PMC: 11397239.
DOI: 10.3390/plants13172492.
Capsaicin exerts synergistic pro-apoptotic effects with cisplatin in TSCC through the calpain pathway via TRPV1.
Zhou X, Zhao Q, Li Z, Liu X, Wang Y, Wu F
J Cancer. 2024; 15(15):4801-4817.
PMID: 39132151
PMC: 11310884.
DOI: 10.7150/jca.98075.
Targeting Transient Receptor Potential Melastatin-2 (TRPM2) Enhances Therapeutic Efficacy of Third Generation EGFR Inhibitors against EGFR Mutant Lung Cancer.
Chen Z, Vallega K, Boda V, Quan Z, Wang D, Fan S
Adv Sci (Weinh). 2024; 11(35):e2310126.
PMID: 39044361
PMC: 11425210.
DOI: 10.1002/advs.202310126.
Promising Role of Alkaloids in the Prevention and Treatment of Thyroid Cancer and Autoimmune Thyroid Disease: A Comprehensive Review of the Current Evidence.
Di Dalmazi G, Giuliani C, Bucci I, Mascitti M, Napolitano G
Int J Mol Sci. 2024; 25(10).
PMID: 38791433
PMC: 11121374.
DOI: 10.3390/ijms25105395.
Lipopolysaccharide pretreatment increases the sensitivity of the TRPV1 channel and promotes an anti-inflammatory phenotype of capsaicin-activated macrophages.
Vasek D, Fikarova N, Markova V, Honc O, Pacakova L, Porubska B
J Inflamm (Lond). 2024; 21(1):17.
PMID: 38790047
PMC: 11127439.
DOI: 10.1186/s12950-024-00391-0.
Anti-cancer activity and mechanism of flurbiprofen organoselenium compound RY-1-92 in non-small cell lung cancer.
Cui B, Cheng X, Zhang X, Chen L, Pang W, Liu Y
RSC Med Chem. 2024; 15(5):1737-1745.
PMID: 38784458
PMC: 11110739.
DOI: 10.1039/d4md00058g.
Function and mechanism of action of the TRPV1 channel in the development of triple-negative breast cancer.
Yan Z, Huang H, Wang Q, Kong Y, Liu X
Acta Biochim Biophys Sin (Shanghai). 2024; 56(7):957-962.
PMID: 38734935
PMC: 11322878.
DOI: 10.3724/abbs.2024068.
Transient Receptor Potential Ankyrin 1 Ion Channel Is Expressed in Osteosarcoma and Its Activation Reduces Viability.
Hudhud L, Rozmer K, Kecskes A, Pohoczky K, Bencze N, Buzas K
Int J Mol Sci. 2024; 25(7).
PMID: 38612571
PMC: 11011947.
DOI: 10.3390/ijms25073760.
Immunomodulatory Prodrug Micelles Imitate Mild Heat Effects to Reshape Tumor Microenvironment for Enhanced Cancer Immunotherapy.
Ngo T, Wang K, Pan W, Ruan T, Lin Y
ACS Nano. 2024; 18(7):5632-5646.
PMID: 38344992
PMC: 10883120.
DOI: 10.1021/acsnano.3c11186.
A journey from molecule to physiology and tools for drug discovery targeting the transient receptor potential vanilloid type 1 (TRPV1) channel.
Amaya-Rodriguez C, Carvajal-Zamorano K, Bustos D, Alegria-Arcos M, Castillo K
Front Pharmacol. 2024; 14:1251061.
PMID: 38328578
PMC: 10847257.
DOI: 10.3389/fphar.2023.1251061.
Research trends and frontier hotspots of TRPV1 based on bibliometric and visualization analyses.
Zeng J, Lu Y, Chu H, Lu L, Chen Y, Ji K
Heliyon. 2024; 10(2):e24153.
PMID: 38293347
PMC: 10827456.
DOI: 10.1016/j.heliyon.2024.e24153.